Basis for Biochemical Discordance Between Activated Partial Thromboplastin Time and Anti-factor Xa in Patients with Continuous Flow Left Ventricular Assist Device on Unfractionated Heparin Infusion

被引：0
|
作者：
Yarmohammadi, Hirad
Feng, Amy J.
Alraies, Chadi M.
Thenappan, Thenappan
Colvin, Monica
John, Ranjit
Eckman, Peter
Pritzker, Marc
Adatya, Sirtaz
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Ventricular assist devices; Thrombosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19105
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Anti-Xa concentration better than activated partial thromboplastin time for the monitoring of unfractionated heparin treatment
    Moumneh, T.
    Mallecian, Y.
    Calmes, A.
    Lacour, E.
    Roy, P. M.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 360 - 361
  • [42] Concordance Between Active Partial Thromboplastin Time and Anti-Factor Xa Assays in Neurocritically Ill Patients Receiving Subcutaneous Heparin Prophylaxis
    Shinn, Grace
    Berger, Karen
    Roh, David
    Doyle, Kevin
    Boehme, Amelia K.
    Connolly, Edward Sander
    Park, Soojin
    Agarwal, Sachin
    Claassen, Jan
    Der-Nigoghossian, Caroline
    [J]. NEUROHOSPITALIST, 2023, 13 (03): : 221 - 227
  • [43] Anticoagulation in syncardia total artificial heart recipients: anti-factor Xa or activated partial thromboplastin time?
    Monteagudo-Vela, Maria
    Bowles, Christopher
    Raj, Binu
    Robinson, Derek
    Simon, Andre
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2022, 34 (02) : 322 - 325
  • [44] The use of activated partial thromboplastin time versus antifactor Xa assay in monitoring continuous unfractionated heparin infusion therapy in obstetric intensive care unit
    Hany V. Zaki
    Marwa A.K. Elbeialy
    Ahmed M. Soliman
    [J]. Ain-Shams Journal of Anesthesiology, 11
  • [45] Standardization of Anti-Xa Assay and its Comparison with Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin Therapy
    Thalappil, Vijisha
    Anand, Jeyanthi
    Keepanasseril, Anish
    Kar, Rakhee
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (03) : 432 - 436
  • [46] The use of activated partial thromboplastin time versus antifactor Xa assay in monitoring continuous unfractionated heparin infusion therapy in obstetric intensive care unit
    Zaki, Hany, V
    Elbeialy, Marwa A. K.
    Soliman, Ahmed M.
    [J]. AIN SHAMS JOURNAL OF ANESTHESIOLOGY, 2019, 11 (1)
  • [47] Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation
    Liveris, Anna
    Bello, Ricardo A.
    Friedmann, Patricia
    Duffy, Melissa A.
    Manwani, Deepa
    Killinger, James S.
    Rodriquez, Daniel
    Weinstein, Samuel
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : E72 - E79
  • [48] Discordance between activated partial thromboplastin time and heparin level measured with anti-Xa assay in antithrombin-deficient plasma
    Yi, A. K.
    Stevic, I
    Gantioqui, J.
    Lau, K. K.
    Roberts, R.
    Chan, A. K.
    Chan, H. H.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 803 - 803
  • [49] IMPROVING CLINICAL DECISION MAKING FOR HEPARINIZED PATIENTS WITH DISCORDANT ANTI-FACTOR XA ACTIVITY AND ACTIVATED PARTIAL THROMBOPLASTIN TIME.
    Gombar, Saurabh
    Krishnan, Anandi
    Zehnder, James
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 40 - 40
  • [50] IS ANTI-FACTOR XA MONITORING BETTER THAN ACTIVATED PARTIALTHROMBOPLASTIN TIME (APTT) IN ACHIEVING THERAPEUTIC RESPONSE TO UNFRACTIONATED HEPARIN?
    Manzanades, Yuri
    [J]. NURSING IN CRITICAL CARE, 2021, 26 : 30 - 31
12345